Correlation Between Abbott Laboratories and Regulus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Abbott Laboratories and Regulus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abbott Laboratories and Regulus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abbott Laboratories and Regulus Therapeutics, you can compare the effects of market volatilities on Abbott Laboratories and Regulus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abbott Laboratories with a short position of Regulus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abbott Laboratories and Regulus Therapeutics.
Diversification Opportunities for Abbott Laboratories and Regulus Therapeutics
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Abbott and Regulus is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Abbott Laboratories and Regulus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regulus Therapeutics and Abbott Laboratories is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abbott Laboratories are associated (or correlated) with Regulus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regulus Therapeutics has no effect on the direction of Abbott Laboratories i.e., Abbott Laboratories and Regulus Therapeutics go up and down completely randomly.
Pair Corralation between Abbott Laboratories and Regulus Therapeutics
Considering the 90-day investment horizon Abbott Laboratories is expected to generate 45.78 times less return on investment than Regulus Therapeutics. But when comparing it to its historical volatility, Abbott Laboratories is 4.98 times less risky than Regulus Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Regulus Therapeutics is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 149.00 in Regulus Therapeutics on September 2, 2024 and sell it today you would earn a total of 12.00 from holding Regulus Therapeutics or generate 8.05% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Abbott Laboratories vs. Regulus Therapeutics
Performance |
| Timeline |
| Abbott Laboratories |
| Regulus Therapeutics |
Abbott Laboratories and Regulus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Abbott Laboratories and Regulus Therapeutics
The main advantage of trading using opposite Abbott Laboratories and Regulus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abbott Laboratories position performs unexpectedly, Regulus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regulus Therapeutics will offset losses from the drop in Regulus Therapeutics' long position.| Abbott Laboratories vs. AbbVie Inc | Abbott Laboratories vs. Eli Lilly and | Abbott Laboratories vs. Bristol Myers Squibb | Abbott Laboratories vs. Johnson Johnson |
| Regulus Therapeutics vs. Tenax Therapeutics | Regulus Therapeutics vs. Verastem | Regulus Therapeutics vs. Pulmatrix | Regulus Therapeutics vs. Cellectar Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |